AIM
ARNA

Artemis Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Artemis Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,430
Closed -$1.4M – 331
2021
Q3 		$1.4M Buy
23,430
+1,199
+5% +$70.8K 0.01% 272
2021
Q2 		$1.52M Buy
+22,231
New +$1.45M 0.01% 256

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Artemis Investment Management's ARNA Position: Q4 2021 in Review

Artemis Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 23,430 shares — an estimated $1.4M sold.

Artemis Investment Management first reported a position in ARNA in Q2 2021 and held it in 2 quarters. The position peaked at $1.52M in Q2 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Artemis Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Artemis Investment Management sold 23,430 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $1.4M.
  • Artemis Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 2 quarters.
  • Artemis Investment Management's Arena Pharmaceuticals Inc position peaked at $1.52M in Q2 2021.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Artemis Investment Management's 13F filing for Q4 2021, filed 8 Feb 2022.